Navigation Links
Flexpoint on Target for Release of Disposable Directional ColonoScope with Haemoband Surgical, LTD.
Date:9/17/2013

DRAPER, Utah, Sept. 17, 2013 /PRNewswire/ -- Flexpoint Sensor Systems, Inc. (http://www.flexpoint.com/), today announced they expect to complete both Phase Two and Phase Three of development of the colonoscope application during the remainder of 2013. The company will receive milestone cash payments for each stage of the development process.

Phase Two will be finished upon delivery of the revised electronic and sensor package.  Phase Two completion will include working prototypes to be used for lab testing.  The final phase will include several working colonoscope devices and the associated electronics in preparation for successful medical trails and gathering the information necessary for completion of the required governmental certifications.  Phase Two is nearing conclusion. The completed systems should be delivered for Phase Two and the commencement of Phase Three should begin by the end of September.  

There are about 5 million procedures per year in the US alone with growth expected as population ages in industrial nations. 

"The product has superior accuracy and resolution over traditional sensor designs and is disposable after one use.  At full production this is the most promising consistent revenue stream of our products.  Phase Two has included refinements to the system and actual testing of the completed systems.  After successful meetings between the two companies last week, it became clear that we are on track to deliver the innovative, inexpensive, accurate product that Haemoband Surgical requires.  We are pleased with the results and look forward to delivering the sensor, electronics and hand-held monitors to Haemoband by the end of the month.   It is anticipated, upon approvals and certifications of the product, that we will enter into a long term Manufacturing and Supply agreement with Haemoband.  This product should be widely available during the first half of 2014," stated Flexpoint CEO Clark Mower.

About Haemoband Surgical Ltd
Haemoband Surgical was founded in 2005 in Belfast, Northern Ireland, by Essam Ghareeb and Colin Foster. Mr Ghareeb's profession as a lower gastrointestinal surgeon, and Mr Foster's experiences in the medical marketplace and in bringing products to a global market, led to the design, development and launch of Haemoband, the first automatic multi-action, pre-loaded, disposable ligator onto the global market.  Haemoband Surgical works to the highest levels of quality possible and has achieved many quality certifications.  The most recent of which is a FDA 510k clearance. For further information please visit www.haemoband.com

About Flexpoint:
Flexpoint Sensor Systems, Inc. (FLXT), (http://www.flexpoint.com/) is an innovative technology firm specializing in developing products that feature the Company's patented Bend Sensor® and related technology.  The Bend Sensor® is a groundbreaking sensing solution that is revolutionizing applications in the automotive, safety, medical and industrial industries. The Bend Sensor's single-layer, thin film construction cuts costs and mechanical bulk while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. Flexpoint's technology and expertise have been recognized by the world's elite business and academic innovators for over 17 years. The company is setting a new standard for sensing solutions in the "smart" age of technology. 

Forward-Looking Statements
This press release contains certain forward-looking statements.  Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Contact Information:
Flexpoint Sensor Systems
Clark Mower, President
801-568-5111

Brokers and Analysts:
Chesapeake Group
410-825-3930

 


'/>"/>
SOURCE Flexpoint Sensor Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexpoint Announces Universal Settlement Involving the Medical Bed and Related Technologies
2. Flexpoint Announces Progress on the Medical Bed and Related Technologies
3. Sales of Flexpoint Sensors Increases Substantially in January
4. Flexpoint Completes Certification for Pressure Relief Device
5. Flexpoint to Develop New Sensor Type
6. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
7. New Drug that Delivers Targeted Radiation Minimizes Pain and May Extend Prostate Cancer Survival
8. arGEN-X Identifies Potent Antibody Antagonists against Complex Chronic Pain Target Nav1.7
9. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
10. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
11. MultiCell Technologies and Genisphere Evaluate Targeted Delivery of MCT-485, a Noncoding miRNA for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 AcelRx ... focused on the development and commercialization of innovative ... announced that it will release fourth quarter and ... March 2nd, 2017. AcelRx management will host an ... (1:30 p.m. Pacific Time) on March 2 nd ...
(Date:2/23/2017)... COTTAGE, New York , February 23, 2017 /PRNewswire/ ... health implications arising from increasing caseload for varicose veins ... recorded across the globe are prompting the adoption of ... latest study on global endovenous laser therapy ... attention towards aftereffects of lifestyle choices and consequences of ...
(Date:2/23/2017)... Research and Markets has announced the addition ... Forecast to 2025" report to their offering. ... The Global Endoscopy Market is ... next decade to reach approximately $47.6 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... Lawn, NJ (PRWEB) , ... February 23, 2017 ... ... specializing in thought leadership , media relations, content marketing, social media management, ... With several clients already in the state and in nearby New Hampshire, Massachusetts ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... interactive publication where generations converge and explore the world from different perspectives. By ... Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
Breaking Medicine News(10 mins):